Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia.
Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Nat Commun. 2024 Apr 29;15(1):3387. doi: 10.1038/s41467-024-47576-y.
Influenza B viruses (IBVs) cause substantive morbidity and mortality, and yet immunity towards IBVs remains understudied. CD8 T-cells provide broadly cross-reactive immunity and alleviate disease severity by recognizing conserved epitopes. Despite the IBV burden, only 18 IBV-specific T-cell epitopes restricted by 5 HLAs have been identified currently. A broader array of conserved IBV T-cell epitopes is needed to develop effective cross-reactive T-cell based IBV vaccines. Here we identify 9 highly conserved IBV CD8 T-cell epitopes restricted to HLA-B07:02, HLA-B08:01 and HLA-B35:01. Memory IBV-specific tetramerCD8 T-cells are present within blood and tissues. Frequencies of IBV-specific CD8 T-cells decline with age, but maintain a central memory phenotype. HLA-B07:02 and HLA-B08:01-restricted NP epitope-specific T-cells have distinct T-cell receptor repertoires. We provide structural basis for the IBV HLA-B07:02-restricted NS1 (11-mer) and HLA-B*07:02-restricted NP epitope presentation. Our study increases the number of IBV CD8 T-cell epitopes, and defines IBV-specific CD8 T-cells at cellular and molecular levels, across tissues and age.
乙型流感病毒(IBV)会导致相当大的发病率和死亡率,但针对 IBV 的免疫仍然研究不足。CD8 T 细胞通过识别保守表位提供广泛的交叉反应性免疫,并减轻疾病严重程度。尽管 IBV 负担沉重,但目前仅鉴定出 18 种受 5 种 HLA 限制的 IBV 特异性 T 细胞表位。需要更广泛的保守的 IBV T 细胞表位来开发有效的基于交叉反应性 T 细胞的 IBV 疫苗。在这里,我们鉴定了 9 种高度保守的受 HLA-B07:02、HLA-B08:01 和 HLA-B35:01 限制的 IBV CD8 T 细胞表位。记忆性 IBV 特异性四聚体 CD8 T 细胞存在于血液和组织中。IBV 特异性 CD8 T 细胞的频率随年龄增长而下降,但仍保持中央记忆表型。HLA-B07:02 和 HLA-B08:01 限制的 NP 表位特异性 T 细胞具有独特的 T 细胞受体库。我们为 IBV HLA-B07:02 限制的 NS1(11 聚体)和 HLA-B*07:02 限制的 NP 表位呈递提供了结构基础。我们的研究增加了 IBV CD8 T 细胞表位的数量,并在细胞和分子水平上定义了跨组织和年龄的 IBV 特异性 CD8 T 细胞。